API and formulation manufacturers where regulatory quality and working capital determine what growth is possible.
API and formulation manufacturers run two businesses at once: a chemical process business with real working-capital intensity, and a regulated quality operation where a single audit finding can close a market.
Most mid-size units in this sector are funded expensively and informally. Promoter loans, supplier credit, and short-term borrowing cover a cash-conversion cycle that a properly structured banking facility would fund at a fraction of the cost — but the books are rarely clean enough for a bank to underwrite.
We clean the financials, renegotiate and restructure the banking limits, and put in the costing and quality-linked reporting that makes the business fundable at institutional rates rather than informal ones.
How we work in Pharma & API Manufacturing
Clean the books, renegotiate banking limits, and structure proper facilities to replace expensive informal credit.
Real margin visibility by product and by batch, including the quality overhead most units carry unmeasured.
Documentation and controls that hold up to a customer audit, a regulator, or an acquirer's diligence.
Capabilities
Proof
Capital & Finance
A mid-size API manufacturer was running on expensive informal credit. We renegotiated banking limits, cleaned the books, and structured a proper CC facility: reducing cost of capital by 30%.
Tell us where the business actually is and we will tell you what we would do first. No deck required.